Trending stocks today
Elanco Animal Health (ELAN-N)
NYSE:ELAN
13.26
0.22
(1.69%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 1 opinions in the last 12 months.
Elanco Animal Health, with symbol ELAN-N, was spun off from Eli Lilly in 2018. Their recent report showed a mixed performance, with their pet business missing guidance for the current quarter, but they are taking steps to address this by selling their Aqua business to Merck Animal Health, announcing restructuring and job cuts, and planning to increase cash flow conversions. Experts have a cautious but hopeful outlook for the company.
$16.260
Unknown
- «
- ‹
- 1
- ›
- »
Elanco Animal Health(ELAN-N) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Elanco Animal Health(ELAN-N) Frequently Asked Questions
What is Elanco Animal Health stock symbol?
Elanco Animal Health is a American stock, trading under the symbol ELAN-N on the New York Stock Exchange (ELAN). It is usually referred to as NYSE:ELAN or ELAN-N
Is Elanco Animal Health a buy or a sell?
In the last year, 1 stock analyst published opinions about ELAN-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Elanco Animal Health.
Is Elanco Animal Health a good investment or a top pick?
Elanco Animal Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Elanco Animal Health.
Why is Elanco Animal Health stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Elanco Animal Health worth watching?
In the last year, there was no coverage of Elanco Animal Health published on Stockchase.
What is Elanco Animal Health stock price?
On 2024-04-26, Elanco Animal Health (ELAN-N) stock closed at a price of $13.26.
Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.